Advances in delivery vectors for gene therapy in liver cancer

Area of Science:

• Oncology
• Gene Therapy
• Biotechnology

Background:

• Hepatocellular carcinoma (HCC) is a major global cancer with limited effective treatments.
• Gene therapy presents a potential solution for improving HCC outcomes.
• Safe and efficient delivery vectors are crucial for successful gene therapy.

Purpose of the Study:

• To review advancements in viral and nonviral vectors for hepatocellular carcinoma (HCC) gene therapy.
• To explore the impact of new gene editing technologies on HCC treatment.
• To highlight studies and clinical trials utilizing these delivery systems.

Main Methods:

• Review of current literature on viral vectors (adenoviral, retroviral, adeno-associated viral) for HCC.
• Analysis of nonviral vectors including nanoparticles, liposomes, exosomes, and virosomes for gene delivery.
• Discussion of emerging gene editing technologies and their application in HCC therapy.

Main Results:

• Viral vectors have been modified for enhanced safety and delivery capacity in HCC gene therapy.
• Nonviral vectors like nanoparticles and exosomes show promise for HCC gene delivery.
• Gene editing technologies are advancing the potential of HCC gene therapy.

Conclusions:

• Significant progress has been made in developing safe and effective gene delivery vectors for HCC.
• Nonviral vectors and gene editing offer new avenues for HCC treatment.
• Further research and clinical trials are essential to realize the full potential of gene therapy for HCC.